Opportunity ID: 333977

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-DK-21-016
Funding Opportunity Title: Characterization of Islet-derived Extracellular Vesicles for Improved Detection, Monitoring, Classification, and Treatment of Type 1 Diabetes (R01 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Food and Nutrition
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.847 — Diabetes, Digestive, and Kidney Diseases Extramural Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jun 03, 2021
Last Updated Date: Jun 03, 2021
Original Closing Date for Applications: Nov 03, 2021
Current Closing Date for Applications: Nov 03, 2021
Archive Date: Dec 09, 2021
Estimated Total Program Funding:
Award Ceiling: $500,000
Award Floor:

Eligibility

Eligible Applicants: Native American tribal organizations (other than Federally recognized tribal governments)
Private institutions of higher education
Public and State controlled institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
State governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Independent school districts
County governments
Native American tribal governments (Federally recognized)
For profit organizations other than small businesses
Special district governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public housing authorities/Indian housing authorities
City or township governments
Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: This initiative will support the development of tools and experimental platforms for the purification and characterization of Extracellular Vesicles (EV) originating from the human pancreatic islet and its broader tissue environment in healthy individuals, and individuals with T1D or at-risk of developing the disease. It will also support the exploration of the contribution of pancreatic EV biology to islet function, dysfunction and T1D disease initiation; the development of EV-based diagnostic tools for disease monitoring and classification; and the use of pancreatic EV biology to identify novel therapeutic targets.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-21-016.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
grantsinfo@nih.gov
Email:grantsinfo@nih.gov

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
grantsinfo@nih.gov
Email: grantsinfo@nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-G Use for due dates on or after January 25, 2022 PKG00269866 Oct 28, 2021 Nov 03, 2021 View
FORMS-F Use for due dates on or before January 24, 2022 PKG00267528 Oct 03, 2021 Jan 24, 2022 View

Package 1

Mandatory forms

333977 RR_SF424_5_0-5.0.pdf

333977 PHS398_CoverPageSupplement_5_0-5.0.pdf

333977 RR_OtherProjectInfo_1_4-1.4.pdf

333977 PerformanceSite_4_0-4.0.pdf

333977 RR_KeyPersonExpanded_4_0-4.0.pdf

333977 PHS398_ResearchPlan_4_0-4.0.pdf

333977 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

333977 RR_Budget_3_0-3.0.pdf

333977 RR_SubawardBudget30_3_0-3.0.pdf

333977 PHS398_ModularBudget_1_2-1.2.pdf

333977 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 2

Mandatory forms

333977 RR_SF424_2_0-2.0.pdf

333977 PHS398_CoverPageSupplement_5_0-5.0.pdf

333977 RR_OtherProjectInfo_1_4-1.4.pdf

333977 PerformanceSite_2_0-2.0.pdf

333977 RR_KeyPersonExpanded_2_0-2.0.pdf

333977 PHS398_ResearchPlan_4_0-4.0.pdf

333977 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

333977 RR_Budget_1_4-1.4.pdf

333977 RR_SubawardBudget30_1_4-1.4.pdf

333977 PHS398_ModularBudget_1_2-1.2.pdf

333977 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-11T10:39:01-05:00

Share This Post, Choose Your Platform!

About the Author: